益母草碱减轻类风湿关节炎中成纤维样滑膜细胞介导的滑膜炎与关节破坏
该研究从类风湿关节炎(RA)患者滑膜组织分离成纤维样滑膜细胞,体外评估益母草碱对促炎细胞因子、基质金属蛋白酶(MMP)、迁移和侵袭的影响,并检测核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)信号通路。结果显示益母草碱显著减少IL-1β、IL-6、IL-8、TNFα及MMP-1、MMP-3产生,抑制滑膜细胞迁移和侵袭,并通过抑制IκBα磷酸化与降解、阻止NF-κB p65核转位及抑制p38和JNK(未影响ERK)通路发挥作用。在胶原诱导性关节炎(CIA)小鼠中,腹腔注射益母草碱减轻滑膜炎症、关节破坏及血清IL-1β、IL-6、TNFα水平。
要点
- 益母草碱减少RA成纤维样滑膜细胞产生IL-1β、IL-6、IL-8、TNFα及MMP-1、MMP-3。
- 益母草碱抑制RA成纤维样滑膜细胞迁移和侵袭,并阻断NF-κB及p38/JNK通路。
- CIA小鼠中腹腔注射益母草碱减轻滑膜炎症、关节破坏及血清IL-1β、IL-6、TNFα。
核心结论
- 益母草碱通过NF-κB和MAPK通路减轻RA滑膜炎症与关节破坏,具有作为RA治疗剂的潜力。
研究设计与样本
- 研究从RA患者滑膜组织分离成纤维样滑膜细胞进行体外实验,并在CIA小鼠中评估益母草碱的体内效应。
主要发现
- 益母草碱处理显著降低RA成纤维样滑膜细胞产生IL-1β、IL-6、IL-8、TNFα及MMP-1、MMP-3。
- 益母草碱抑制RA成纤维样滑膜细胞的迁移和侵袭。
- 益母草碱通过抑制IκBα磷酸化和降解、阻止NF-κB p65核转位来削弱TNFα诱导的NF-κB信号。
- 益母草碱抑制p38和JNK MAPK信号通路而不影响ERK信号。
- CIA小鼠腹腔注射益母草碱减轻滑膜炎症、关节破坏及血清IL-1β、IL-6、TNFα水平。
临床怎么用
- 益母草碱在体外和CIA小鼠中显示抗炎和关节保护作用,但尚未提供人体RA治疗的疗效或安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the role of leonurine in the regulation of synovial inflammation and joint destruction inRA. METHODS: Fibroblast-like synoviocytes were isolated from synovial tissue from RA patients. Pro-inflammatory cytokine and MMP expression was evaluated using real-time PCR and a cytometric bead array. Cell migration and invasion in vitro were measured using the Boyden chamber method and the scratch assay, respectively. Protein expression was measured by western blotting. Nuclear factor kappa B (NF-κB) nuclear translocation was detected by immunofluorescence. The in vivo effect of leonurine was evaluated in mice with CIA. RESULTS: Leonurine treatment significantly decreased the production of pro-inflammatory cytokines (IL-1β, IL-6, IL-8 and TNFα) and MMPs (MMP-1 and MMP-3) and suppressed the migration and invasion of RA fibroblast-like synoviocytes. The molecular analysis revealed that leonurine impaired TNFα-induced NF-κB signalling by inhibiting the phosphorylation and degradation of inhibitor of NF-κB alpha (IκBα) and subsequently preventing the nuclear translocation of the NF-κB p65 subunit. Leonurine also inhibited the p38 and Jun N-terminal kinase mitogen-activated protein kinases signalling pathways without affecting ERK signalling. Intraperitoneal injection of leonurine reduced synovial inflammation, joint destruction and the serum IL-1β, IL-6 and TNFα levels in mice with CIA. CONCLUSION: Our findings show that leonurine reduces synovial inflammation and joint destruction in RA through the NF-κB and mitogen-activated protein kinases pathways. Leonurine has potential as a therapeutic agent for RA.
引用
- Li N, Xu Q, Liu Q, et al. Leonurine attenuates fibroblast-like synoviocyte-mediated synovial inflammation and joint destruction in rheumatoid arthritis. Rheumatology (Oxford). 2017. PMID: 28431044. doi:10.1093/rheumatology/kex142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。